Winton Group LTD Halozyme Therapeutics, Inc. Transaction History

Winton Group LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $4.99 Million - $6.21 Million	148,130 New	148,130 $6.03 Million
Q1 2023 May 12, 2023	BUY	$32.86 - $55.7 $559,934 - $949,128	17,040 New	17,040 $650,000
Q2 2022 Aug 10, 2022	SELL	$37.35 - $48.3 $4.66 Million - $6.03 Million	-124,869 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$31.97 - $41.06 $2.44 Million - $3.14 Million	-76,417 Reduced 37.96%	124,869 $4.98 Million
Q4 2021 Feb 10, 2022	BUY	$31.82 - $40.75 $5.07 Million - $6.49 Million	159,304 Added 379.46%	201,286 $8.09 Million
Q3 2021 Oct 28, 2021	SELL	$38.47 - $46.42 $270,905 - $326,889	-7,042 Reduced 14.36%	41,982 $1.71 Million
Q2 2021 Aug 10, 2021	BUY	$38.84 - $51.31 $112,208 - $148,234	2,889 Added 6.26%	49,024 $2.23 Million
Q1 2021 Jul 21, 2021	SELL	$39.51 - $51.45 $126,471 - $164,691	-3,201 Reduced 6.49%	46,135 $1.92 Million
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $3.94 Million - $6.66 Million	-152,765 Reduced 75.59%	49,336 $2.11 Million
Q3 2020 Oct 30, 2020	BUY	$25.74 - $29.63 $2.74 Million - $3.15 Million	106,406 Added 111.19%	202,101 $5.31 Million
Q2 2020 Aug 05, 2020	BUY	$16.25 - $26.81 $175,695 - $289,869	10,812 Added 12.74%	95,695 $2.57 Million
Q1 2020 May 11, 2020	SELL	$13.9 - $21.83 $212,544 - $333,802	-15,291 Reduced 15.26%	84,883 $1.53 Million
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $1.19 Million - $1.56 Million	79,775 Added 391.07%	100,174 $1.78 Million
Q3 2019 Nov 08, 2019	BUY	$15.2 - $17.69 $310,064 - $360,858	20,399 New	20,399 $316,000

488

122M

208K

66.3K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.97B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.